Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magnesium sulfate in normal saline is an intravenous investigational preparation used in clinical research to evaluate its anesthetic-sparing and analgesic properties. Magnesium sulfate acts as a non-competitive NMDA (N-methyl-D-aspartate) receptor antagonist and calcium channel blocker, which modulates pain signaling and reduces the requirement for opioids and volatile anesthetics during and after surgery. In clinical trials, such as those conducted by Aretaieion University Hospital, it is administered as a bolus followed by a continuous infusion to patients undergoing elective procedures like laparoscopic cholecystectomy to improve recovery outcomes and manage postoperative pain. The preparation consists of the inorganic salt magnesium sulfate dissolved in a 0.9% sodium chloride solution.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium sulfate + sodium chloride.